Apex Healthcare is an API manufacturer based in India. It holds 10 active US drug master files across a filed portfolio of 9 molecules. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 15 June 2023 as VAI. Customs aggregates show $8.1M of exports covering 305 molecules to 46 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Ankleshwar, India | 3006509185 |
| Bharuch, India | Not on file |
| bharuch 393 002, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| CDSCO (India) | None | 3 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $931K | 20 |
| 2025 | Not reported | $8.1M | 46 |
| 2024 | Not reported | $6.2M | 41 |
| 2023 | Not reported | $4.5M | 33 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Apex Healthcare comes back tiered against every other supplier able to file there.
Start for free